Drug Shortage Report for PRO-AMOX-250

Last updated on 2024-02-14 History
Report ID 175133
Drug Identification Number 00644331
Brand name PRO-AMOX-250
Common or Proper name AMOX 250
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 150ml
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-11-21
Actual start date 2022-11-28
Estimated end date 2023-05-05
Actual end date 2023-05-05
Shortage status Resolved
Updated date 2024-02-14
Company comments under allocation, sous allocation
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2024-02-14 English Compare
v26 2023-05-06 English Compare
v25 2023-05-05 French Compare
v24 2023-05-05 English Compare
v23 2023-05-01 French Compare
v22 2023-05-01 English Compare
v21 2023-04-12 French Compare
v20 2023-04-12 English Compare
v19 2023-04-12 French Compare
v18 2023-04-12 English Compare
v17 2023-03-22 French Compare
v16 2023-03-22 English Compare
v15 2023-03-13 French Compare
v14 2023-03-13 English Compare
v13 2023-01-04 French Compare
v12 2023-01-04 English Compare
v11 2022-12-20 French Compare
v10 2022-12-20 English Compare
v9 2022-12-05 French Compare
v8 2022-12-05 English Compare

Showing 1 to 20 of 27